Company Search:
Advanced Search
Sponsored Links
Anhui Fengyuan Pharmaceutical Company Snapshot
Anhui Fengyuan Pharmaceutical operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Anhui Fengyuan Pharmaceutical with three other companies in this sector in CHINA : Chengdu Kanghong Pharmaceutical Group Co Ltd (2018 sales of 2.92 billion Chinese Renmimbi [US$413.05 million] of which 100% was Pharmaceutical Manufacturing), Sihuan Pharmaceutical Holdings Group Ltd (2.92 billion Chinese Renmimbi [US$413.05 million] of which 100% was Pharmaceutical Prods), and Jiuzhitang Company Limited (3.12 billion Chinese Renmimbi [US$442.12 million] of which 95% was Pharmacuetical Industry).

Sales Analysis. During the year ended December of 2018, sales at Anhui Fengyuan Pharmaceutical were 3.01 billion Chinese Renmimbi (US$426.64 million). This is an increase of 16.9% versus 2017, when the company's sales were 2.58 billion Chinese Renmimbi. This was the third consecutive year of growth at Anhui Fengyuan Pharmaceutical. Sales of Medicine Manufacturing saw an increase that was more than double the company's growth rate: sales were up 64.2% in 2018, from 1.01 billion Chinese Renmimbi to 1.66 billion Chinese Renmimbi. Not all segments of Anhui Fengyuan Pharmaceutical experienced an increase in sales in 2018: sales of Other Operations fell 15.9% to 56.62 million Chinese Renmimbi. (However, this segment's sales were only a very small portion of the company's overall sales). Anhui Fengyuan Pharmaceutical also experienced decreases in sales in Medicine Retail Circulation (down 13.7% to 1.29 billion Chinese Renmimbi) .
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Anhui Fengyuan Pharmaceutical
  Stock Performance Chart for Anhui Fengyuan Pharmaceutical
  Stock Data: Recent Stock Performance:
  Current Price (3/20/2020): 6.65
(Figures in Chinese Renmimbi)
1 Week -0.7%   13 Weeks -7.8%  
4 Weeks 3.6%   52 Weeks -4.3%  
Anhui Fengyuan Pharmaceutical Key Data:
  Ticker: 000153 Country: China
  Exchanges: SZN Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2018 Sales 3,013,395,364
(Year Ending Jan 2019).
Employees: 4,758
  Currency: Chinese Renmimbi Market Cap: 2,075,739,180
  Fiscal Yr Ends: December Shares Outstanding: 312,141,230
  Share Type: A Gu Closely Held Shares: 97,573,878
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.